Investors/Syncona

3 London Mempool companies backed by Syncona

Rank =128 of 430 on the investor leaderboard. No source we have says it led a round in any of them.

See them on the mapCounts only deals named in a source we fetched

Inner London. Coloured dots are the portfolio, grey dots the rest of the map.

Portfolio by sector

Health33 Health companies

Portfolio on the map (3)

Purespring Therapeutics£115M
London gene therapy company targeting kidney podocytes to treat diseases such as IgA nephropathy.
Health · Kidney Gene Therapy · Fastest growing
source: purespringtx.com
Beacon Therapeutics
Clinical-stage gene therapy company developing treatments for retinal diseases such as X-linked retinitis pigmentosa.
Health · Ophthalmic Gene Therapy · Fastest growing
source: beacontx.com
Quell Therapeutics
Develops engineered CAR-Treg cell therapies for autoimmune disease and organ transplant rejection.
Health · Cell Therapy · Up and coming
source: quell-tx.com

Often alongside

We list Syncona on a company only when a page we fetched names it as an investor. Its real London portfolio is likely bigger. Know a deal we missed? Suggest a fix with a source. How we count